Published in World J Gastroenterol on November 14, 2015
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol (2008) 9.14
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Global challenges in liver disease. Hepatology (2006) 4.55
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology (2010) 3.43
Hepatitis B virus infection. Lancet (2014) 2.78
Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology (2010) 2.44
Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol (2013) 1.89
Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol (2003) 1.79
Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci (2010) 1.78
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest (2003) 1.58
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology (2006) 1.43
Chemokines in liver inflammation and fibrosis. Semin Liver Dis (2010) 1.42
Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology (2006) 1.30
Liver transplantation for acute-on-chronic liver failure. Hepatol Int (2009) 1.23
Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol (2009) 1.20
Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology (2008) 1.16
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat (2010) 1.13
Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol (2010) 1.13
APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis (2013) 1.12
Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol (2003) 1.11
Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl (2006) 1.10
A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol (2010) 1.03
Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients. Hepatogastroenterology (2012) 1.03
Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol (2011) 1.01
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol (2009) 1.00
Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B. J Clin Virol (2010) 1.00
Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol (2007) 0.99
Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.97
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. Eur J Med Res (2008) 0.96
Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc (2007) 0.96
Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology (2014) 0.95
Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol Lett (2012) 0.94
[Prewarning of severe acute aggravation of chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi (2010) 0.92
Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Ann Hepatol (2012) 0.92
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol (2005) 0.91
Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant. World J Gastroenterol (2004) 0.91
Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.91
The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem (2005) 0.90
Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. J Med Virol (2011) 0.90
Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care (2014) 0.89
Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection. World J Gastroenterol (2012) 0.88
Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS. J Viral Hepat (2013) 0.87
Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate. Clin Exp Rheumatol (2008) 0.87
Acute-on-chronic liver failure: a review. Ther Clin Risk Manag (2014) 0.87
Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation (2013) 0.87
Serum ferritin concentration predicts mortality in patients with hepatitis B virus-related acute on chronic liver failure. Arch Med Res (2014) 0.86
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int (2014) 0.85
Apolipoprotein and lipid abnormalities in chronic liver failure. Braz J Med Biol Res (1997) 0.84
Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure. Hepatol Res (2014) 0.84
Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure. Hepatology (2015) 0.83
Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure. World J Gastroenterol (2013) 0.83
Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure. PLoS One (2012) 0.83
Distinct quasispecies characteristics and positive selection within precore/core gene in hepatitis B virus HBV associated acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.82
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol (2014) 0.82
Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure. J Gastroenterol (2013) 0.81
Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol (2012) 0.81
Geranylgeranylacetone prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine GRO1 and induction of heat shock proteins. J Gastrointest Surg (2008) 0.80
A single institution experience with living donor liver transplantation for acute-on-chronic hepatitis B liver failure. Hepatogastroenterology (2011) 0.80
Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol (2012) 0.80
Ammonia-induced energy disorders interfere with bilirubin metabolism in hepatocytes. Arch Biochem Biophys (2014) 0.80
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol (2013) 0.79
Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study. Medicine (Baltimore) (2015) 0.79
MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study. Scand J Gastroenterol (2009) 0.79
Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases. Hepat Mon (2013) 0.79
Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. Int J Infect Dis (2015) 0.78
Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure. Ann Hepatol (2015) 0.78
Employment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure. J Transl Med (2015) 0.78
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One (2015) 0.77
A novel prognostic score for acute-on-chronic hepatitis B liver failure. J Huazhong Univ Sci Technolog Med Sci (2015) 0.77
[Analysis of prognostic factors for patients with acute-on-chronic liver failure]. Zhonghua Gan Zang Bing Za Zhi (2009) 0.77
[The evolution and characteristics of liver function classification: from Child to MELD]. Zhonghua Gan Zang Bing Za Zhi (2004) 0.76
Model for End-Stage Liver Disease (MELD) score does not predict outcomes of hepatitis B-induced acute-on-chronic liver failure in transplant recipients. Transplant Proc (2014) 0.76
On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study. BMC Res Notes (2013) 0.76
Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure. PLoS One (2014) 0.76
Serum peptide profiles during progression of chronic hepatitis B virus infection to liver failure. J Viral Hepat (2010) 0.76